Fineotex Chemical Limited · NSE:FCL

Fineotex Chemical — 9M FY2019 Earnings Presentation

24 slides from Fineotex Chemical's earnings presentation, Feb 19, 2019

  1. Slide 1: Fineotex Chemical Limited – Investor / Earnings Presentation cover letter

    FINEOTEX” A Speciality Chemical Producing Public Listed Company 0-200) x Pence, g s fom) (H); @re SRT IE Gg 1s0 14001 February 19, 2019 To, General Manager, The Manager, Listing Department, Listing & Compliance Department BSE Limited, The National Stock Exchange of India Limited P.J. Towers, Dalal S

  2. Slide 2: Where Dependability Counts… Earnings Presentation 9M/Q3-FY19

    FINEOTEX CHEMICAL LIMITED 9M/ Q3-FY19 Where Dependability Counts… EARNINGS PRESENTATION

  3. Slide 3: Executive Summary

    ~ EXECUTIVESUMMARY ©

  4. Slide 4: Executive Summary

    FINEOTEX® EXECUTIVE SUMMARY OVERVIEW BUSINESS MIX KEY STRENGTHS FY18 FINANCIALS (I-GAAP-Consolidated)  Fineotex Group founded in 1979  Fineotex is one of India’s largest  Strong Balance Sheet with Zero  Income – INR 1,431 MN , year is engaged in manufacturing of and most progressive speciality D

  5. Slide 5: Company Overview

    COMPANY OVERVIEW 4

  6. Slide 6: Company Overview

    FINEOTEX® COMPANY OVERVIEW  Fineotex Group was established in 1979 by Mr. Surendra Industry wise Revenue Domestic Revenue Tibrewala. Break-up Break-up Adhesives  FCL was incorporated as a public limited company in 2007. The 1% Other Chemicals South East Fertilizer 2% company was listed on Bombay S

  7. Slide 7: Accreditations

    FINEOTEX® ACCREDITATIONS SA 8000 (Social Accountability ISO 9001:20015 ISO 14001:2015 OHSAS 18001:2007 Management System) Fastest growing company in chemical Recognized as a ZDHC (Zero Discharge Hazardous Chemical) manufacturing by IPF at Bombay Stock Star Export House Exchange 6

  8. Slide 8: Financial Overview

    FINANCIAL OVERVIEW 7

  9. Slide 9: 9M/Q3-FY19 Financial Highlights

    FINEOTEX® 9M/ Q3-FY19 FINANCIAL HIGHLIGHTS (IND-AS)  Q3-FY19 performance (Standalone):  9M-FY19 performance (Standalone): • Revenue : INR 282 Mn; Growth of 21.0% YoY • Revenue : INR 803 Mn; Growth of 18.8% YoY • EBITDA : INR 58 Mn; Growth of 7.4% YoY • EBITDA : INR 185 Mn; Growth of 7.6% YoY • EBI

  10. Slide 10: Quarterly Income Statement (Standalone)

    FINEOTEX® QUARTERLY- INCOME STATEMENT STANDALONE (As Per IND-AS) INCOME STATEMENT (INR Mn) Q3-FY19 Q2-FY19 Q-o-Q Revenue 282 269 4.8% Expenses 224 219 2.3% EBITDA 58 50 16.0% EBITDA Margins (%) 20.57% 18.59% 198 Bps Other Income 6 (2) NA Depreciation 2 2 - Finance Cost 1 2 (50.0)% Exceptional Items

  11. Slide 11: Nine Months Income Statement (Standalone)

    FINEOTEX® NINE MONTHS - INCOME STATEMENT STANDALONE (As Per IND-AS) INCOME STATEMENT (INR Mn) 9M-FY19 9M-FY18 Y-o-Y Revenue 803 676 18.8% Expenses 618 504 22.6% EBITDA 185 172 7.6% EBITDA Margins (%) 23.04% 25.44% (240) Bps Depreciation 7 4 75.0% Finance Cost 5 3 66.7% Exceptional Items (4) - NA PBT

  12. Slide 12: Quarterly Income Statement (Consolidated)

    FINEOTEX® QUARTERLY- INCOME STATEMENT CONSOLIDATED (As Per IND-AS) INCOME STATEMENT (INR Mn) Q3-FY19 Q2-FY19 Q-o-Q Revenue 460 432 6.5% Expenses 375 352 6.5% EBITDA 85 80 6.3% EBITDA Margins (%) 18.48% 18.52% (4) Bps Other Income 5 (3) NA Depreciation 3 3 - Finance Cost 2 3 (33.3)% Exceptional Items

  13. Slide 13: Nine Months Income Statement (Consolidated)

    FINEOTEX® NINE MONTHS - INCOME STATEMENT CONSOLIDATED (As Per IND-AS) INCOME STATEMENT (INR Mn) 9M-FY19 9M-FY18 Y-o-Y Revenue 1,321 1,027 28.6% Expenses 1,061 812 30.7% EBITDA 260 215 20.9% EBITDA Margins (%) 19.68% 20.93% (125) Bps Depreciation 7 5 40.0% Finance Cost 7 4 75.0% Exceptional Items (4)

  14. Slide 14: Historical Standalone Income Statement

    FINEOTEX® HISTORICAL STANDALONE INCOME STATEMENT (As Per I-GAAP) INCOME STATEMENT (INR Mn) FY14 FY15 FY16 FY17 FY18 Revenue 535 650 681 757 921 Expenses 486 537 498 565 680 EBITDA 49 113 183 192 241 EBITDA Margins (%) 9.16% 17.38% 26.87% 25.36% 26.17% Other Income 37 48 45 44 73 Depreciation 2 4 5 6

  15. Slide 15: Standalone Balance Sheet (I-GAAP)

    FINEOTEX® STANDALONE BALANCE SHEET (As Per I-GAAP) PARTICULARS (INR Mn) FY 13 FY14 FY 15 FY16 FY17 PARTICULARS (INR Mn) FY 13 FY14 FY15 FY16 FY17 EQUITIES & LIABILITIES ASSETS Shareholder Funds 546 601 707 837 956 Non Current Assets 225 244 576 678 772 (A) Share Capital 112 112 224 225 223 (A) Fixed

  16. Slide 16: Standalone Balance Sheet (IND-AS)

    FINEOTEX® STANDALONE BALANCE SHEET (As Per IND-AS) PARTICULARS (INR Mn) FY17 FY18 H1-FY19 PARTICULARS (INR Mn) FY17 FY18 H1-FY19 EQUITIES & LIABILITIES ASSETS Shareholder Funds Non Current Assets Equity Share Capital 223 223 223 Property, Plant & Equipment 163 180 235 Other Equity 798 988 1,061 Capi

  17. Slide 17: Standalone Financial Performance

    FINEOTEX® STANDALONE FINANCIAL PERFORMANCE (As Per I-GAAP) Revenue EBITDA M (%) Net Profit 1000 921 30.0% 250 222 900 800 757 25.0% 26.9% 26.2% 200 700 650 25.4% 681 20.0% 151 159 17.4% 600 535 150 500 15.0% 112 400 100 300 10.0% 58 200 9.2% 50 5.0% 100 0 0.0% 0 FY14 FY15 FY16 FY17 FY18 FY14 FY15 FY

  18. Slide 18: Historical Consolidated Income Statement

    FINEOTEX® HISTORICAL CONSOLIDATED INCOME STATEMENT (As Per I-GAAP) INCOME STATEMENT (INR Mn) FY14 FY15 FY16 FY17 FY18 Revenue 867 1,020 1,087 1,354 1,431 Expenses 774 855 822 1,055 1,129 EBITDA 93 165 265 299 302 EBITDA Margin (%) 10.73% 16.18% 24.38% 22.08% 21.10% Other Income 28 45 33 43 52 Deprec

  19. Slide 19: Consolidated Balance Sheet (I-GAAP)

    FINEOTEX® CONSOLIDATED BALANCE SHEET (As Per I-GAAP) PARTICULARS (INR Mn) FY 13 FY14 FY 15 FY 16 FY17 PARTICULARS (INR Mn) FY 13 FY14 FY 15 FY 16 FY17 EQUITIES & LIABILITIES ASSETS Shareholder Funds 581 647 763 913 1,060 Non Current Assets 200 224 556 647 743 (A) Share Capital 112 112 224 225 223 (A

  20. Slide 20: Consolidated Balance Sheet (IND-AS)

    FINEOTEX® CONSOLIDATED BALANCE SHEET (As Per IND-AS) PARTICULARS (INR Mn) FY17 FY18 H1-FY19 PARTICULARS (INR Mn) FY17 FY18 H1-FY19 EQUITIES & LIABILITIES ASSETS Shareholder Funds Non Current Assets 173 192 247 Equity Share Capital 223 223 223 Property, Plant & Equipment Other Equity 902 1,135 1,243

  21. Slide 21: Consolidated Financial Performance

    FINEOTEX® CONSOLIDATED FINANCIAL PERFORMANCE (As Per I-GAAP) Revenue EBITDA M (%) Net Profit CASH FLOW FROM OPERATIONS 1,600 30.0% 300 200 1,354 1,431 249 1,400 24.4% 239 180 191 25.0% 250 160 1,200 1,087 22.1% 136 136 1,020 20.0% 200 140 1,000 867 21.1% 170 120 800 10.7% 16.2% 15.0% 150 129 100 600

  22. Slide 22: Capital Market Information

    FINEOTEX® CAPITAL MARKET INFORMATION INCREASE IN PROMOTER HOLDING PRICE DATA (AS ON 31st December, 2018) Promoter Holding (%) Face value (INR) 2.0 Market Price (INR) 36.60 73.0 52 Week H/L (INR) 106.05/29.60 72.0 72.4 72.4 Market Cap (INR Mn) 4,110.1 71.0 71.7 71.7 Equity Shares Outstanding (Mn) 111

  23. Slide 23: Safe Harbour

    FINEOTEX® SAFE HARBOUR This presentation and the accompanying slides (the “Presentation”), which have been prepared by Fineotex Chemical Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  24. Slide 24: Capital Market Information

    FINEOTEX® CAPITAL MARKET INFORMATION INCREASE IN PROMOTER HOLDING PRICE DATA (AS ON 31ST DECEMBER, 2015) Promoter Holding (%) Face value (INR) 2 Market Price (INR) 26.45 75 52 Week H/L (INR) 44.6/17.8 70 70.7 71.7 Market Cap (INR Mn) 2970.3 65 66.3 Equity Shares Outstanding (Mn) 22.5 60 62.5 Free Fl

Fineotex Chemical — 9M FY2019 Earnings Presentation on 6ix